Procurement Summary
Country : USA
Summary : Bulk Pharmaceuticals - Group A (Materiel)
Deadline : 03 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 116957498
Document Ref. No. : 75A50325R00002
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
THIS AMENDMENT IS ISSUED TO REVISE THE SOLICITED QUANTITIES AND REVISE STATEMENT OF WORK SECTION D.3.3 - RETURNS & RECALLS. QUANTITIES ARE REVISED IN RFP ATTACHMENT 1 AND RFP ATTACHMENT 2.
THE CLOSING DATE OF THE SOLICITATION IS ExTENDED TO APRIL 3, 2025, AT 11:00 A.M. (EST).
*********************************************************************************
THIS AMENDMENT IS ISSUED TO PUBLISH ANSWERS TO VENDOR QUESTIONS. PLEASE SEE ATTACHED "ANSWERS TO VENDOR QUESTIONS."
***************************************************
This is a combined synopsis/solicitation for commercial supplies in accordance with FAR Part 12. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This synopsis/solicitation is issued on the basis of full and open competition and is not set aside for small businesses. The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing). The size standard is 1, 300 (number of employees).
The Center for the Strategic National Stockpile (SNS) has a need to procure a variety of FDA-approved pharmaceuticals to maintain minimum stockpiling capabilities for responding to public health events. The Contractor, as an independent organization and not as an agent of the Government, shall furnish all labor, materials, supplies, facilities, equipment, transportation and travel necessary to deliver the acceptable pharmaceuticals. The Contractor shall provide brand name or equal product for the pharmaceuticals listed in Section D - Description/Specifications/Work Statement contained in the Request for Proposals. The pharmaceuticals include the following:
Albuterol Nebulizer Solution, 0.083% - 2.5mg/3ml vial
Amoxicillin/Clavulanate Acid 500mg/125mg tablets
Bactrim DS, sulfamethoxazole 800mg/trimethoprim 160mg, 100 tablets
Doxycycline 25mg/5ml oral suspension, powder, 60ml bottle
Ondansetron HCL 8mg, 30 tablets, bottleb...
Active Contract Opportunity
Notice ID : 75A50325R00002
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: ASPR/ORM-SNS
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
Updated Published Date: Mar 28, 2025 05:49 pm EDT
Original Published Date: Mar 10, 2025 10:28 am EDT
Updated Date Offers Due: Apr 03, 2025 11:00 am EDT
Original Date Offers Due: Mar 31, 2025 11:00 am EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Apr 18, 2025
Original Inactive Date: Apr 15, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: GA USA
Documents
Tender Notice
75A50325R00002_Rev-3.pdf
RFP-Attachment-1-Technical-Product-List-Template.xlsx
RFP-Attachment-2-Business-Template-Rev-3.xlsx
75A50325R00002_Answers-to-Vendor-Questions.pdf
RFP-ATTACHMENT-3-Q-A-Template.docx
RFP-ATTACHMENT-4-Reps-and-Certs.docx
RFP-ATTACHMENT-5-SBCX-Industry-Subcontracting-Guid.pdf